Tuesday, 17 February 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 17 February 2026
News

Judge shields $130M AZ market

Posted 17 February 2026 AM

An 'unprecedented' lightning-quick Federal Court ruling has seen AstraZeneca granted an injunction to protect its most important market in Australia worth $130 million-plus a year.

Justice Kylie Downes granted the interlocutory injunction just six working days after the interlocutory hearing on 6 February, and two months after AstraZeneca began legal proceedings. The injunction prevents Pharmacor from launching a generic version of Forxiga, which it had planned to do on 1 April. It also covers combination products which include the same active ingredient, Xigduo, Qtern, and Sidapvia.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Access & Reimbursement (1)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (4)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.